Tim Moore

Track

Insider profile

Currently holds positions in Kite Pharma Inc and Cerus Corp

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 26% 68% 82%
Transactions
3 67% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President - Technical Operations Kite Pharma Inc March 16, 2016 -
Independent Director Cerus Corp Sept. 6, 2018 -
Tim Moore's trades of Allogene Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
339.02
Quantity 68,050
Value US$2,113,617
Transaction date
Proposed sale
Price
384.78
Quantity 20,993
Value US$4,304,883
US Cerus Corp (CERS)
Transaction date
Purchase
Price
4.75
Quantity 3,614 +84.1%
Value US$17,165
US Cerus Corp (CERS)
Transaction date
Purchase
Price
4.15
Quantity 3,614 +84.1%
Value US$14,998
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-05 2025-02-03
S Sale
56,642 -1.1%
26.01
US$2,418,310 		56,642 -1.1% 26.01 US$2,418,310
2025-02-03 2025-02-03
PrS Proposed sale
68,050
339.02
US$2,113,617 		68,050 339.02 US$2,113,617
2024-04-22 2024-04-22
PrS Proposed sale
20,993
384.78
US$4,304,883 		20,993 384.78 US$4,304,883
2020-02-13 2020-02-11
US Cerus Corp (CERS)
B Purchase
3,614 +84.1%
4.75
US$17,165 		3,614 +84.1% 4.75 US$17,165
2020-02-03 2020-01-29
US Cerus Corp (CERS)
B Purchase
3,614 +84.1%
4.15
US$14,998 		3,614 +84.1% 4.15 US$14,998